フルイチ ヨシヒロ
  古市 好宏
   所属   医学部 医学科(附属足立医療センター)
   職種   准教授
論文種別 原著
言語種別 英語
査読の有無 査読あり
表題 Dual red imaging (novel advanced endoscopy) can increase visibility and can predict the depth in diagnosing esophageal varices.
掲載誌名 正式名:Journal of gastroenterology
略  称:J Gastroenterol
ISSNコード:14355922/09441174
掲載区分国外
巻・号・頁 52(5),pp.568-576
著者・共著者 Furuichi Yoshihiro, Gotoda Takuji, Moriyasu Fuminori, Ogawa Saori, Kasai Yoshitaka, Takeuchi Hirohito, Yoshimasu Yuu, Sano Takatomo, Sugimoto Katsutoshi, Kawai Takashi, Kobayashi Yoshiyuki, Nakamura Ikuo, Itoi Takao
発行年月 2017/05
概要 BACKGROUND:Dual red imaging (DRI) is a new technology that can increase the visibility of deeper veins compared with narrow band imaging (NBI). As esophageal varices (EVs) are a vascular disease occurring in the submucosal layer, their visibility might be increased by DRI. We prospectively clarified whether the visibility of EVs with red color sign (RCS) can be increased by DRI, and clarified the relation between the visibility scores and the obtained endoscopic ultrasound (EUS) images.METHODS:Forty patients were enrolled. The visibility of the EVs on DRI and NBI endoscopic images was evaluated by five observers in a blinded manner and was compared with a white light image (bad, 0; equal, 1; good, 2). The diameter of the lumen and the depth of the EVs and RCS from the epithelium were measured by EUS. The relation between the visibility scores and the EUS findings was investigated.RESULTS:The DRI scores were 1.66 ± 0.34 for the EV substance and 1.79 ± 0.28 for the RCS, whereas the NBI scores were 0.68 ± 0.38 and 0.41 ± 0.28, respectively. A significant negative correlation was found between the depth and the visibility score (r = -0.505, p = 0.001 for EVs; r = -0.458, p = 0.003 for RCS).CONCLUSIONS:DRI increased the visibility of the EVs and RCS. The visibility of the EVs or RCS in the shallower position was more enhanced by DRI. Visual recognition of the changing degrees of visibility by DRI enables the prediction of the depth of EVs.
DOI 10.1007/s00535-016-1249-2
PMID 27502189